Steris (STE) Profit After Tax Growth (3y) (2021 - 2026)
Steris (STE) Profit After Tax Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 49.66% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | -7.65% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 9.79% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 97.37% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 15.46% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.46% |
| Mar 31, 2026 | 6.00% |
| Dec 31, 2025 | 16.08% |
| Sep 30, 2025 | 37.69% |
| Jun 30, 2025 | 16.96% |
| Mar 31, 2025 | 40.39% |
| Dec 31, 2024 | 6.48% |
| Sep 30, 2024 | 29.04% |
| Jun 30, 2024 | 105.19% |
| Mar 31, 2024 | 20.58% |
| Dec 31, 2023 | 9.08% |
| Sep 30, 2023 | 4.50% |
| Jun 30, 2023 | 13.38% |
| Mar 31, 2023 | 15.16% |
| Dec 31, 2022 | 5.53% |
| Sep 30, 2022 | -74.65% |
| Jun 30, 2022 | 9.23% |
| Mar 31, 2022 | -21.67% |
| Dec 31, 2021 | 44.24% |
| Sep 30, 2021 | -3.41% |